# Claim table — Nicole Sirotek Remdesivir Reel

| Claim | Evidence label | Finding |
|---|---|---|
| Nicole Sirotek said Remdesivir was “killing patients.” | Confirmed quote/source claim | AP and other captures quote Sirotek making this claim at a Ron Johnson event. |
| The clip is “sworn testimony to the United States Senate.” | Needs precision | The source trail supports a Sen. Ron Johnson COVID panel/roundtable in a Senate context; PBC did not confirm oath-taking or a formal Senate committee hearing record. |
| Remdesivir recipients had less than 25% survival after more than two doses. | Not supported by trial evidence checked | AP says Sirotek/American Frontline Nurses did not provide supporting data; major clinical trials did not show increased deaths. |
| Remdesivir was universally beneficial. | Too broad | ACTT-1 supported shorter recovery time in hospitalized adults; WHO Solidarity found little/no overall mortality effect in hospitalized patients. Benefit depends on timing/patient group. |
| Remdesivir has real safety warnings. | Confirmed | Veklury prescribing information lists hypersensitivity/infusion reactions, transaminase elevations, lab monitoring and adverse reactions such as nausea/ALT/AST increases. |
| PBC gives medical advice on whether to take Remdesivir. | No | This article is a source-check, not medical advice. Treatment decisions require licensed medical care and current guidelines. |